and evaluation of taste-masked orodispersible tablets of fluoxetine hydrochloride for the treatment of depression.

Drug Dev Ind Pharm

Faculty of Pharmacy, Pharmaceutics and Industrial Pharmacy Department, Al-Azhar University, Nasr City, Egypt.

Published: April 2021

Aim: Fluoxetine (FLX) has become the first-line drug in the pharmacotherapy of patients with depression. However, it has a strong unpleasant bitter taste, leading to the failure to complete the therapy. In this study, FLX is formulated into orodispersible tablets (ODTs) characterized by a fast release with an acceptable taste.

Method: FLX ODTs were prepared by the complexation of FLX with β-cyclodextrin (β-CD) for taste-masking, using different super disintegrants, namely crospovidone (CP), croscarmellose sodium (Ccs), sodium starch glycolate (SSG), and indion. The FLX powder blend is estimated for pre-and post-compression parameters. The selected tablet formulations based upon drug release at 40 s with acceptable release patterns are investigated for accelerated stability testing and comparative study with a marketed product.

Results: It was found that all FLX-powder blends have good flow properties; all the prepared tablets complied with the pharmacopeial requirements for the unity of content, weight, friability, and hardness. Moreover, all the tablets obtained acceptable taste after complexation with -CD. The order of release of the drug, regarding super disintegrants used, was as in the following descending order: CP > Ccs > SSG > indion. Accelerated stability study of selected formulation F2 and F6 showed that; there were no considerable changes in physical properties, drug content, and percentage drug release. Furthermore, also the study proved the effectiveness of FLX ODTs as an antidepressant.

Conclusion: The results obtained showed a promising potential of the prepared FLX ODTs for treating depression effectively.

Download full-text PDF

Source
http://dx.doi.org/10.1080/03639045.2021.1908336DOI Listing

Publication Analysis

Top Keywords

flx odts
12
orodispersible tablets
8
super disintegrants
8
drug release
8
accelerated stability
8
flx
7
drug
5
release
5
evaluation taste-masked
4
taste-masked orodispersible
4

Similar Publications

and evaluation of taste-masked orodispersible tablets of fluoxetine hydrochloride for the treatment of depression.

Drug Dev Ind Pharm

April 2021

Faculty of Pharmacy, Pharmaceutics and Industrial Pharmacy Department, Al-Azhar University, Nasr City, Egypt.

Aim: Fluoxetine (FLX) has become the first-line drug in the pharmacotherapy of patients with depression. However, it has a strong unpleasant bitter taste, leading to the failure to complete the therapy. In this study, FLX is formulated into orodispersible tablets (ODTs) characterized by a fast release with an acceptable taste.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!